Enregistrement - Lobbyistes-conseils

Objets

• Industrie
• Propriété intellectuelle
• Questions constitutionnelles
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Canada's Access to Medicine Regime (CAMR) and proposed amendments. Merck Frosst Canada seeking to ensure that those threatened by serious diseases have timely access to medicines for the diseases and that a research climate that will help to produce cures for other diseases is maintained.
• Health Canada's Blue Print for Renewal: Transforming Canada's Approach to Regulating Health Products and Food to renew the process for approving drugs. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.
• Patented Medicine Prices Review Board (PMPRB) Pricing Guidelines used by the PMPRB to ensure that prices of patented medicines sold in Canada are not excessive. Merck Frosst Canada seeking to ensure PMPRB Guidelines reflect their mandate of ensuring prices are non-excessive, while ensuring an attractive climate for pharmaceutical research.
• The Government's Science and Technology (S&T) Strategy announced in May 2007 which encourages a more competitive Canadian economy and improved quality of life for Canadians through science and technology. Merck Frosst seeking to ensure S&T Strategy encourages a more competitive environment for biopharmaceutical innovation in Canada.
• The National Pharmaceutical Strategy as agreed to by First Ministers in 2004, with a focus on options for catastrophic pharmaceutical coverage. Merck Frosst Canada seeking to ensure that Canadians' ability to access the medicines they need is increased.

Proposition législative, Projet de loi ou résolution

• Legislative proposals related to Canada's Food and Consumer Safety Action Plan. Merck Frosst Canada seeking to ensure that Canada's safety system for medicines ensures safe and effective medicines for Canadians in a timely manner, consistent with other jurisdictions.

Règlement

• Patented Medicine Prices Review Board (PMPRB) Regulations identifying information to be reported to the PMPRB. Merck Frosst Canada seeking to ensure that the information being collected is consistent with PMPRB's mandate to prevent excessive pricing while ensuring an attractive climate for pharmaceutical research.
• Patented Medicines (Notice of Compliance) Regulations which seek to balance patent rights and cost savings. Merck Frosst Canada seeking to ensure that patent rights are respected and are internationally competitive.

Subvention, Contribution ou autre avantage financier

• National Immunization Strategy. Advocacy to seek continued funding in vaccines.

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Agence de la santé publique du Canada (ASPC)
• Bureau du Conseil privé (BCP)
• Cabinet du Premier ministre (CPM)
• Chambre des communes
• Commission de révision des marchés publics (CRMP)
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Conseil national de recherches (CNRC)
• Finances Canada (FIN)
• Industrie Canada
• Santé Canada (SC)
• Secrétariat du Conseil du Trésor du Canada (SCT)
• Sénat du Canada

Adresse :
16711 TransCanada Highway
Kirkland, QC  H9H 3L1
Canada

Numéro de téléphone : 514-428-7920

Représentant du client

Carlos Dourado, President

Renseignements sur la société mère